• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 Sugen/低氧小鼠肺动脉高压的发展中,IL-33/ST2 受体依赖性信号通路。

IL-33/ST2 receptor-dependent signaling in the development of pulmonary hypertension in Sugen/hypoxia mice.

机构信息

Medicine, University of California, San Diego, La Jolla, California, USA.

VA San Diego Healthcare System, La Jolla, California, USA.

出版信息

Physiol Rep. 2022 Feb;10(3):e15185. doi: 10.14814/phy2.15185.

DOI:10.14814/phy2.15185
PMID:35150208
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8839421/
Abstract

Pulmonary arterial hypertension (PAH) is associated with significant morbidity and mortality. PAH is characterized by pulmonary artery remodeling, elevated right ventricular pressure (RVP) and, ultimately, cardiac failure. Pulmonary endothelial cells can sense danger or damage caused by mechanical injury or pathogens through alarmin cytokines. These cytokines can signal proliferation to restore barrier integrity or aberrant hyperproliferation and remodeling. We hypothesized that IL-33 signals pulmonary artery endothelial cells to proliferate under hypertensive conditions during the remodeling response and rise in RVP. To test this hypothesis, pulmonary hypertension (PH) was induced in C57Bl/6J, IL-33 receptor gene deleted (ST2 ) and MYD88 gene deleted (MYD88 ) mice by exposure to 10% O and SU5416 injections (SUHX). RVP, arterial wall thickness, endothelial cell proliferation and IL-33 levels and signaling were evaluated. In response to SUHX. RVP increased in C57Bl/6J mice in response to SUHX (49% male and 70% female; p < 0.0001) and this SUHX response was attenuated in ST2 mice (29% male p = 0.003; 30% female p = 0.001) and absent in MYD88 mice. Wall thickness was increased in SUHX C57Bl/6J mice (p = 0.005), but not in ST2 or MYD88 mice. Proliferating cells were detected in C57Bl/6J mice by flow cytometry (CD31 /BrDU ; p = 0.02) and immunofluorescence methods (Ki-67+). IL-33 was increased by SUHX (p = 0.03) but a genotype effect was not observed (p = 0.76). We observed that in hPAECs, IL-33 expression is regulated by both IL-33 and DLL4. These data suggest IL-33/ST2 signaling is essential for the endothelial cell proliferative response in PH.

摘要

肺动脉高压(PAH)与显著的发病率和死亡率相关。PAH 的特征在于肺动脉重塑、右心室压力(RVP)升高,最终导致心力衰竭。肺内皮细胞可以通过警报细胞因子感知机械损伤或病原体引起的危险或损伤。这些细胞因子可以发出信号促进增殖以恢复屏障完整性或异常的过度增殖和重塑。我们假设,在重塑反应和 RVP 升高期间,IL-33 在高血压条件下信号传递给肺动脉内皮细胞以增殖。为了验证这一假设,我们通过暴露于 10% O 和 SU5416 注射(SUHX)在 C57Bl/6J、IL-33 受体基因缺失(ST2)和 MYD88 基因缺失(MYD88)小鼠中诱导肺动脉高压(PH)。评估了 RVP、动脉壁厚度、内皮细胞增殖以及 IL-33 水平和信号传递。在 SUHX 作用下,C57Bl/6J 小鼠的 RVP 增加(雄性 49%,雌性 70%;p<0.0001),而在 ST2 小鼠中,这种 SUHX 反应减弱(雄性 29%,p=0.003;雌性 30%,p=0.001),在 MYD88 小鼠中则不存在。SUHX C57Bl/6J 小鼠的壁厚度增加(p=0.005),但在 ST2 或 MYD88 小鼠中则没有。通过流式细胞术(CD31/BrDU;p=0.02)和免疫荧光方法(Ki-67+)检测到 C57Bl/6J 小鼠中的增殖细胞。SUHX 增加了 IL-33(p=0.03),但未观察到基因型效应(p=0.76)。我们观察到,在 hPAECs 中,IL-33 的表达受 IL-33 和 DLL4 的调节。这些数据表明,IL-33/ST2 信号在 PH 中的内皮细胞增殖反应中是必不可少的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae6/8839421/4ce11baa2d75/PHY2-10-e15185-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae6/8839421/c5a9bbe1245b/PHY2-10-e15185-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae6/8839421/2d86b7168e56/PHY2-10-e15185-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae6/8839421/2bf5d103b690/PHY2-10-e15185-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae6/8839421/b043923e43f2/PHY2-10-e15185-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae6/8839421/4ce11baa2d75/PHY2-10-e15185-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae6/8839421/c5a9bbe1245b/PHY2-10-e15185-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae6/8839421/2d86b7168e56/PHY2-10-e15185-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae6/8839421/2bf5d103b690/PHY2-10-e15185-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae6/8839421/b043923e43f2/PHY2-10-e15185-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae6/8839421/4ce11baa2d75/PHY2-10-e15185-g002.jpg

相似文献

1
IL-33/ST2 receptor-dependent signaling in the development of pulmonary hypertension in Sugen/hypoxia mice.在 Sugen/低氧小鼠肺动脉高压的发展中,IL-33/ST2 受体依赖性信号通路。
Physiol Rep. 2022 Feb;10(3):e15185. doi: 10.14814/phy2.15185.
2
Role of IL-33 receptor (ST2) deletion in diaphragm contractile and mitochondrial function in the Sugen5416/hypoxia model of pulmonary hypertension.ST2 受体(白细胞介素-33 受体)缺失在 Sugen5416/缺氧诱导的肺动脉高压模型中膈肌收缩和线粒体功能中的作用。
Respir Physiol Neurobiol. 2022 Jan;295:103783. doi: 10.1016/j.resp.2021.103783. Epub 2021 Sep 8.
3
IL-33 Initiates Vascular Remodelling in Hypoxic Pulmonary Hypertension by up-Regulating HIF-1α and VEGF Expression in Vascular Endothelial Cells.IL-33 通过上调血管内皮细胞中 HIF-1α 和 VEGF 的表达引发低氧性肺动脉高压中的血管重塑。
EBioMedicine. 2018 Jul;33:196-210. doi: 10.1016/j.ebiom.2018.06.003. Epub 2018 Jun 18.
4
Reactive oxygen species induced Ca influx via TRPV4 and microvascular endothelial dysfunction in the SU5416/hypoxia model of pulmonary arterial hypertension.活性氧诱导 Ca 内流通过 TRPV4 导致肺动脉高压 SU5416/缺氧模型中小血管内皮功能障碍。
Am J Physiol Lung Cell Mol Physiol. 2018 May 1;314(5):L893-L907. doi: 10.1152/ajplung.00430.2017. Epub 2018 Feb 1.
5
Regulation of mitochondrial fragmentation in microvascular endothelial cells isolated from the SU5416/hypoxia model of pulmonary arterial hypertension.SU5416/低氧肺动脉高压模型中小鼠肺微血管内皮细胞中线粒体碎片化的调控。
Am J Physiol Lung Cell Mol Physiol. 2019 Nov 1;317(5):L639-L652. doi: 10.1152/ajplung.00396.2018. Epub 2019 Aug 28.
6
Role of interleukin-1 receptor 1/MyD88 signalling in the development and progression of pulmonary hypertension.白细胞介素-1 受体 1/MyD88 信号通路在肺动脉高压发生发展中的作用。
Eur Respir J. 2016 Aug;48(2):470-83. doi: 10.1183/13993003.01448-2015. Epub 2016 Jul 13.
7
Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension.雌激素在肺动脉高压实验模型中对右心室功能的直接和间接保护作用
Am J Physiol Heart Circ Physiol. 2014 Aug 1;307(3):H273-83. doi: 10.1152/ajpheart.00758.2013. Epub 2014 Jun 6.
8
Isolated heart model demonstrates evidence of contractile and diastolic dysfunction in right ventricles from rats with sugen/hypoxia-induced pulmonary hypertension.离体心脏模型显示,在舒更葡糖/低氧诱导的肺动脉高压大鼠的右心室中存在收缩和舒张功能障碍的证据。
Physiol Rep. 2017 Oct;5(19). doi: 10.14814/phy2.13438. Epub 2017 Oct 16.
9
Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.萝卜硫素可预防肺动脉高压右心室损伤并减少肺血管重构。
Am J Physiol Heart Circ Physiol. 2020 Apr 1;318(4):H853-H866. doi: 10.1152/ajpheart.00321.2019. Epub 2020 Feb 28.
10
Paeoniflorin Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition.芍药苷通过抑制血管内皮向间质转化缓解慢性低氧/SU5416 诱导的肺动脉高压。
Drug Des Devel Ther. 2020 Mar 19;14:1191-1202. doi: 10.2147/DDDT.S235207. eCollection 2020.

引用本文的文献

1
Microbiota Transplant Therapy Is Safe and Feasible in Pulmonary Arterial Hypertension.微生物群移植疗法在肺动脉高压中是安全可行的。
JACC Basic Transl Sci. 2025 Aug 12;10(9):101347. doi: 10.1016/j.jacbts.2025.101347.
2
Serum IL-33/ST2 Axis Expression in Acute Exacerbations of COPD: Correlation with Pulmonary Function.慢性阻塞性肺疾病急性加重期血清白细胞介素-33/ST2轴表达:与肺功能的相关性
Int J Chron Obstruct Pulmon Dis. 2025 Jul 23;20:2581-2587. doi: 10.2147/COPD.S514152. eCollection 2025.
3
Multimodal Screening for Pulmonary Arterial Hypertension in Systemic Scleroderma: Current Methods and Future Directions.

本文引用的文献

1
The Ca-dependent pathway contributes to changes in the subcellular localization and extracellular release of interleukin-33.Ca 依赖性途径有助于白细胞介素-33 的亚细胞定位和细胞外释放的变化。
Biochem Biophys Res Commun. 2020 Oct 1;530(4):699-705. doi: 10.1016/j.bbrc.2020.07.127. Epub 2020 Aug 5.
2
Smooth Muscle Phenotype in Idiopathic Pulmonary Hypertension: Hyper-Proliferative but not Cancerous.特发性肺动脉高压中的平滑肌表型:高增殖但非癌变。
Int J Mol Sci. 2019 Jul 22;20(14):3575. doi: 10.3390/ijms20143575.
3
Cigarette Smoke Triggers IL-33-associated Inflammation in a Model of Late-Stage Chronic Obstructive Pulmonary Disease.
系统性硬化症中肺动脉高压的多模式筛查:当前方法与未来方向
Medicina (Kaunas). 2024 Dec 27;61(1):19. doi: 10.3390/medicina61010019.
4
A comprehensive analysis of genes associated with hypoxia and cuproptosis in pulmonary arterial hypertension using machine learning methods and immune infiltration analysis: is a key gene in the cuproptosis process.使用机器学习方法和免疫浸润分析对肺动脉高压中与缺氧和铜死亡相关基因的综合分析:是铜死亡过程中的关键基因。
Front Med (Lausanne). 2024 Sep 26;11:1435068. doi: 10.3389/fmed.2024.1435068. eCollection 2024.
香烟烟雾在晚期慢性阻塞性肺疾病模型中引发 IL-33 相关炎症。
Am J Respir Cell Mol Biol. 2019 Nov;61(5):567-574. doi: 10.1165/rcmb.2018-0402OC.
4
Identification of the IL-33 protein segment that controls subcellular localization, extracellular secretion, and functional maturation.鉴定控制细胞内定位、细胞外分泌和功能成熟的 IL-33 蛋白片段。
Cytokine. 2019 Jul;119:1-6. doi: 10.1016/j.cyto.2019.02.015. Epub 2019 Mar 8.
5
An overview of the 6th World Symposium on Pulmonary Hypertension.第六届世界肺动脉高压研讨会综述。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.02148-2018. Print 2019 Jan.
6
Haemodynamic definitions and updated clinical classification of pulmonary hypertension.血流动力学定义和肺动脉高压的最新临床分类。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01913-2018. Print 2019 Jan.
7
Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension.晚期糖基化终末产物受体(RAGE)在肺动脉高压患者平滑肌细胞异常增殖中的关键作用。
PLoS One. 2018 Sep 4;13(9):e0203046. doi: 10.1371/journal.pone.0203046. eCollection 2018.
8
Chromatin regulates IL-33 release and extracellular cytokine activity.染色质调控白细胞介素-33 的释放和细胞外细胞因子活性。
Nat Commun. 2018 Aug 14;9(1):3244. doi: 10.1038/s41467-018-05485-x.
9
IL-33 Initiates Vascular Remodelling in Hypoxic Pulmonary Hypertension by up-Regulating HIF-1α and VEGF Expression in Vascular Endothelial Cells.IL-33 通过上调血管内皮细胞中 HIF-1α 和 VEGF 的表达引发低氧性肺动脉高压中的血管重塑。
EBioMedicine. 2018 Jul;33:196-210. doi: 10.1016/j.ebiom.2018.06.003. Epub 2018 Jun 18.
10
A network map of IL-33 signaling pathway.白细胞介素-33信号通路网络图。
J Cell Commun Signal. 2018 Sep;12(3):615-624. doi: 10.1007/s12079-018-0464-4. Epub 2018 Apr 28.